Tracking the Structural Development of Amyloid Precursors in the Insulin B Chain and the Inhibition Effect by Fibrinogen.

Amyloid fibrils are abnormal protein aggregates associated with several amyloidoses and neurodegenerative diseases. Prefibrillar intermediates, which emerge before amyloid fibril formation, play an important role in structure formation. Therefore, to prevent fibril formation, the mechanisms underpinning the structural development of prefibrillar intermediates must be elucidated. An insulin-derived peptide, the insulin B chain, is known for its stable accumulation of prefibrillar intermediates. In this study, the structural development of B chain prefibrillar intermediates and their inhibition by fibrinogen (Fg) were monitored by transmission electron microscopy (TEM) and small-angle X-ray scattering (SAXS) combined with solid-state nuclear magnetic resonance spectroscopy (NMR) and size exclusion chromatography. TEM images obtained in a time-lapse manner demonstrated that prefibrillar intermediates were wavy rod-like structures emerging from initial non-rod-like aggregates, and their bundling was responsible for protofilament formation. Time-resolved SAXS revealed that the prefibrillar intermediates became thicker and longer as a function of time. Solid-state NMR measurement suggested a β-sheet formation around Ala14 residue was crucial for the structural conversion from prefibrillar intermediates to amyloid fibril. These observations suggested that prefibrillar intermediates serve as reaction fields for amyloid nucleation and its structural propagation. Time-resolved SAXS also demonstrated that Fg prevented elongation of the prefibrillar intermediates by forming specific complexes together, which implied that regulation of the length of prefibrillar intermediates upon Fg binding was the factor suppressing the prefibrillar intermediate elongation. The fibril formation mechanism and the inhibition strategy found in this study will be helpful in seeking appropriate methods against amyloid-related diseases.

[1]  A. Tamura,et al.  Pathway Dependence of the Formation and Development of Prefibrillar Aggregates in Insulin B Chain , 2022, Molecules.

[2]  P. Smertenko,et al.  Silver nanoparticles as inhibitors of insulin amyloid formation: A fluorescence study , 2021, Journal of Molecular Liquids.

[3]  S. Sendilvelan,et al.  Effective inhibition of insulin amyloid fibril aggregation by nickel(II) complexes containing heterocyclic thiosemicarbazones , 2021, European Biophysics Journal.

[4]  Y. Goto,et al.  Multistep changes in amyloid structure that are induced by cross-seeding on a rugged energy landscape , 2020, bioRxiv.

[5]  M. Delcea,et al.  Biopolymer-coated gold nanoparticles inhibit human insulin amyloid fibrillation , 2020, Scientific Reports.

[6]  R. Tycko,et al.  Molecular structure of a prevalent amyloid-β fibril polymorph from Alzheimer's disease brain tissue , 2020, Proceedings of the National Academy of Sciences.

[7]  C. Sigurdson,et al.  Cryo-EM structure and polymorphism of Aβ amyloid fibrils purified from Alzheimer’s brain tissue , 2019, Nature Communications.

[8]  A. Tamura,et al.  Structural Insights into the Inhibition of Amyloid Fibril Formation by Fibrinogen via Interaction with Prefibrillar Intermediates. , 2019, Biochemistry.

[9]  J. Ryu,et al.  Fibrinogen in neurological diseases: mechanisms, imaging and therapeutics , 2018, Nature Reviews Neuroscience.

[10]  Nadinath B. Nillegoda,et al.  Protein Disaggregation in Multicellular Organisms. , 2018, Trends in biochemical sciences.

[11]  E. Chatani,et al.  Recent progress on understanding the mechanisms of amyloid nucleation , 2018, Biophysical Reviews.

[12]  R. Pappu,et al.  Profilin reduces aggregation and phase separation of huntingtin N-terminal fragments by preferentially binding to soluble monomers and oligomers , 2018, The Journal of Biological Chemistry.

[13]  A. Tamura,et al.  A specific form of prefibrillar aggregates that functions as a precursor of amyloid nucleation , 2018, Scientific Reports.

[14]  A. Murzin,et al.  Cryo-EM structures of Tau filaments from Alzheimer’s disease brain , 2017, Nature.

[15]  C. Dobson,et al.  Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade. , 2017, Annual review of biochemistry.

[16]  J. Brender,et al.  Inhibition of Insulin Amyloid Fibrillation by a Novel Amphipathic Heptapeptide , 2016, The Journal of Biological Chemistry.

[17]  D. Eisenberg,et al.  The formation, function and regulation of amyloids: insights from structural biology , 2016, Journal of internal medicine.

[18]  M. Gobbi,et al.  Clusterin Binds to Aβ1–42 Oligomers with High Affinity and Interferes with Peptide Aggregation by Inhibiting Primary and Secondary Nucleation* , 2016, The Journal of Biological Chemistry.

[19]  N. Barooah,et al.  Inhibition and disintegration of insulin amyloid fibrils: a facile supramolecular strategy with p-sulfonatocalixarenes. , 2016, Chemical communications.

[20]  M. Sugiyama,et al.  Early aggregation preceding the nucleation of insulin amyloid fibrils as monitored by small angle X-ray scattering , 2015, Scientific Reports.

[21]  H. Imamura,et al.  Stepwise Organization of the β-Structure Identifies Key Regions Essential for the Propagation and Cytotoxicity of Insulin Amyloid Fibrils* , 2014, The Journal of Biological Chemistry.

[22]  S. Jackson,et al.  Hsp90 inhibits α-synuclein aggregation by interacting with soluble oligomers. , 2013, Journal of molecular biology.

[23]  Akira Naito,et al.  Characterization of the spherical intermediates and fibril formation of hCT in HEPES solution using solid-state 13C-NMR and transmission electron microscopy. , 2013, Physical chemistry chemical physics : PCCP.

[24]  Yujin E. Kim,et al.  Molecular chaperone functions in protein folding and proteostasis. , 2013, Annual review of biochemistry.

[25]  A. Naito,et al.  Role of aromatic residues in amyloid fibril formation of human calcitonin by solid-state 13C NMR and molecular dynamics simulation. , 2013, Physical chemistry chemical physics : PCCP.

[26]  Mark R. Wilson,et al.  Roles of extracellular chaperones in amyloidosis. , 2012, Journal of molecular biology.

[27]  F. Chiti,et al.  Protein misfolded oligomers: experimental approaches, mechanism of formation, and structure-toxicity relationships. , 2012, Chemistry & biology.

[28]  Isao Ando,et al.  Chemical shift tensor - the heart of NMR: Insights into biological aspects of proteins. , 2010, Progress in nuclear magnetic resonance spectroscopy.

[29]  Jesper Søndergaard Pedersen,et al.  A SAXS study of glucagon fibrillation. , 2009, Journal of molecular biology.

[30]  C. Dobson,et al.  α2-Macroglobulin and Haptoglobin Suppress Amyloid Formation by Interacting with Prefibrillar Protein Species* , 2009, Journal of Biological Chemistry.

[31]  F. Sanz,et al.  Hsp104 targets multiple intermediates on the amyloid pathway and suppresses the seeding capacity of Abeta fibrils and protofibrils. , 2008, Journal of molecular biology.

[32]  Y. Ishii,et al.  Evidence of fibril-like β-sheet structures in a neurotoxic amyloid intermediate of Alzheimer's β-amyloid , 2007, Nature Structural &Molecular Biology.

[33]  C. Dobson,et al.  The extracellular chaperone clusterin influences amyloid formation and toxicity by interacting with prefibrillar structures , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[34]  Mireille Dumoulin,et al.  The extracellular chaperone clusterin potently inhibits human lysozyme amyloid formation by interacting with prefibrillar species. , 2007, Journal of molecular biology.

[35]  Heather T. McFarlane,et al.  Atomic structures of amyloid cross-β spines reveal varied steric zippers , 2007, Nature.

[36]  Dmitri I Svergun,et al.  A Helical Structural Nucleus Is the Primary Elongating Unit of Insulin Amyloid Fibrils , 2007, PLoS biology.

[37]  Hui Zhou,et al.  Heat shock protein 70 inhibits alpha-synuclein fibril formation via interactions with diverse intermediates. , 2006, Journal of molecular biology.

[38]  C. Dobson,et al.  Heat Shock Protein 70 Inhibits α-Synuclein Fibril Formation via Preferential Binding to Prefibrillar Species* , 2005, Journal of Biological Chemistry.

[39]  C. Dobson.  Protein folding and misfolding , 2003, Nature.

[40]  R. Tycko.  Insights into the amyloid folding problem from solid-state NMR. , 2003, Biochemistry.

[41]  L. K. Baker,et al.  Oligomeric and Fibrillar Species of Amyloid-β Peptides Differentially Affect Neuronal Viability* , 2002, The Journal of Biological Chemistry.

[42]  Christopher M. Dobson,et al.  The protofilament structure of insulin amyloid fibrils , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[43]  S. Lindquist,et al.  Nucleated conformational conversion and the replication of conformational information by a prion determinant. , 2000, Science.

[44]  R. Hodges,et al.  1H, 13C and 15N random coil NMR chemical shifts of the common amino acids. I. Investigations of nearest-neighbor effects , 1995, Journal of biomolecular NMR.

[45]  O. Kratky,et al.  SMALL-ANGLE SCATTERING OF BENCE-JONES PROTEIN. , 1964, Biochimica et biophysica acta.

[46]  S. Broersma.  Viscous Force Constant for a Closed Cylinder , 1960 .

[47]  A. Naito,et al.  Conformational transitions and fibrillation mechanism of human calcitonin as studied by high‐resolution solid‐state 13C NMR , 2000, Protein science : a publication of the Protein Society.